IONS vs LIEN · rev $226.6M vs P/E 6.5, $223.4M cap
Ionis Pharmaceuticals Inc (IONS) versus Chicago Atlantic BDC, Inc. (LIEN) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Chicago Atlantic BDC, Inc. (LIEN) is a asset management company listed on US.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
LIEN does not have a complete income-statement cache yet.
IONS currently screens at market cap $12.28B. LIEN currently screens at market cap $223.4M and trailing P/E 6.5.
Not investment advice. Open the IONS and LIEN stock pages for the full models.
Not investment advice.